LXEOLexeo Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Lexeo Therapeutics, Inc. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LXEO본 종목 | $343M#6 | — | 1.5x#2 | 525.0x#9 | — | -1.7%#7 | -16706.0%#9 | -42.5%#7 | — | — | -23.4%#10 | — |
| EDIT | $415M#2 | — | 3.9x#9 | 10.2x#5 | 25.4%#5 | 32.5%#4 | -394.9%#6 | -152.0%#11 | — | — | -9.7%#9 | — |
| OCGN | $361M#3 | — | — | 81.8x#8 | 8.8%#7 | -25.9%#9 | -1425.7%#7 | — | — | — | -24.7%#11 | — |
| AGEN | $354M#4 | 2.6x#3 | — | 3.1x#3 | 10.4%#6 | 98.7%#2 | -17.7%#2 | — | — | — | 71.9%#4 | — |
| XFOR | $353M#5 | 2.5x#2 | 2.3x#7 | 10.1x#4 | 1273.2%#2 | -111.5%#13 | -247.4%#4 | -50.9%#8 | -582.0%#4 | — | 10.0%#8 | — |
| GRML | $454M#1 | — | 7.8x#11 | — | — | -71.6%#11 | — | -18.2%#4 | -14.6%#2 | — | -89.8%#14 | — |
| CMPX | $341M#7 | — | 2.1x#5 | — | -100.0%#9 | -34.7%#10 | — | -40.0%#6 | — | — | -48.5%#13 | — |
| IPSC | $333M#8 | — | 1.4x#1 | 3.1x#2 | 1556.8%#1 | 92.4%#3 | -15.8%#1 | -4.1%#2 | -9.3%#1 | — | 269.3%#1 | — |
| IKT | $320M#9 | — | 2.1x#6 | — | -100.0%#9 | -75.4%#12 | — | -31.5%#5 | — | — | 49.7%#6 | — |
| SABS | $318M#10 | 14.6x#4 | 1.5x#3 | — | -100.0%#9 | 138.9%#1 | — | 6.2%#1 | — | — | 24.3%#7 | — |
| FATE | $303M#11 | — | 2.0x#4 | 45.6x#7 | -51.2%#8 | 26.8%#5 | -2222.4%#8 | -88.8%#9 | -102.3%#3 | — | 154.3%#3 | — |
| PALI | $278M#12 | 2.5x#1 | 2.3x#8 | — | — | -16.2%#8 | — | -13.8%#3 | — | — | 167.6%#2 | — |
| LCTX | $259M#13 | — | 4.3x#10 | 17.8x#6 | 53.2%#4 | -241.4%#14 | -251.6%#5 | -104.3%#10 | — | — | -33.4%#12 | — |
| STRO | $253M#14 | — | — | 2.5x#1 | 65.2%#3 | 15.9%#6 | -154.5%#3 | — | — | — | 68.6%#5 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-19.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice